Immunologic Research

Papers
(The TQCC of Immunologic Research is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine186
Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients172
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy147
COVID 19: a clue from innate immunity112
The role of Th17 cells in psoriasis60
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity54
Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview40
How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative37
PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy37
Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development36
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review34
Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease34
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review30
Iodoprophylaxis and thyroid autoimmunity: an update27
Tumor-infiltrating B cell is associated with the control of progression of gastric cancer25
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)23
Utility of serological biomarker’ panels for diagnostic accuracy of interstitial lung diseases23
COVID-19 vaccines adverse events: potential molecular mechanisms22
Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis22
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae?20
The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes20
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab20
Effect of interleukin-6, -17, -21, -22, and -23 and STAT3 on signal transduction pathways and their inhibition in autoimmune arthritis19
Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction–based approaches19
Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review19
Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells18
Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment—a population-based cohort study18
Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases18
Jeffrey’s insights: Jeffrey Modell Foundation’s global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment17
Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma17
Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature16
Dexmedetomidine alleviates pulmonary edema through the epithelial sodium channel (ENaC) via the PI3K/Akt/Nedd4-2 pathway in LPS-induced acute lung injury16
A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy16
Trained innate immunity16
Protectin DX ameliorates inflammation in sepsis-induced acute lung injury through mediating PPARγ/NF-κB pathway16
Immune characteristics distinguish patients with severe disease associated with SARS-CoV-215
Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy15
The role of competing mechanisms on Lck regulation14
Blockade of PD-1 and TIM-3 immune checkpoints fails to restore the function of exhausted CD8+ T cells in early clinical stages of chronic lymphocytic leukemia14
Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity13
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis13
Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS1712
Correlation of clinical signs and symptoms of Behçet’s disease with platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR)12
Increased expression of proinflammatory cytokines and iNOS in the neocortical microvasculature of patients with temporal lobe epilepsy12
Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation11
Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages11
Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis11
Comparative structural analyses of selected spike protein-RBD mutations in SARS-CoV-2 lineages10
The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis10
A systematic review on neutrophil extracellular traps and its prognostication role in COVID-19 patients10
COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report10
PD-1 expression is elevated in monocytes from hepatocellular carcinoma patients and contributes to CD8 T cell suppression10
Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome10
Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance10
Big data highlights the association between psoriasis and fibromyalgia: a population-based study9
Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology9
Anti-IL-6 receptor monoclonal antibody as a new treatment of endometriosis9
TLR4 and TNFR1 blockade dampen M1 macrophage activation and shifts them towards an M2 phenotype9
Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis based on randomized controlled trials9
PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency9
ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review8
Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis8
Association between TLR2 polymorphisms (− 196–174 Ins/Del, R677W, R753Q, and P631H) and schizophrenia in a Tunisian population8
Lipocalin 2—not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials8
Effects of functionally diverse calpain system on immune cells8
Lower expression of NINJ1 (Ninjurin 1), a mediator of plasma membrane rupture, is associated with advanced disease and worse prognosis in serous ovarian cancer8
Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement7
The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels7
Delphinidin diminishes in vitro interferon-γ and interleukin-17 producing cells in patients with psoriatic disease7
Activation of autophagy reverses gemcitabine-induced immune inhibition of RAW264.7 macrophages by promoting TNF-α, IL-6 and MHC-II expression7
Platelets differentially modulate CD4+ Treg activation via GPIIa/IIIb-, fibrinogen-, and PAR4-dependent pathways7
Comparative study between human mesenchymal stem cells and etanercept as immunomodulatory agents in rat model of rheumatoid arthritis7
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?7
TREC/KREC levels in children with ataxia-telangiectasia7
Humoral immune response to epidermal growth factor receptor in lung cancer6
COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells6
Effects of whole-body cryotherapy on the innate and adaptive immune response in cyclists and runners6
Azilsartan attenuates lipopolysaccharide-induced acute lung injury via the Nrf2/HO-1 signaling pathway6
High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice6
Obesity, a challenge in the management of inflammatory bowel diseases6
Correction to: Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients6
Vitamin D deficiency leads to the abnormal activation of the complement system6
Immunostimulatory activity of fluoxetine in macrophages via regulation of the PI3K and P38 signaling pathways6
IL-10-producing regulatory B cells are present and functional in primary Sjögren patients6
In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management5
COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators5
The ratio of CD163-positive macrophages to Iba1-positive macrophages is low in the intima in the early stage of cutaneous arteritis5
Potential role of viral infection and B cells as a linker between innate and adaptive immune response in systemic lupus erythematosus5
Cytokine response following perturbation of the cervicovaginal milieu during HPV genital infection5
Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies5
Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installation5
Distorted frequency of dendritic cells and their associated stimulatory and inhibitory markers augment the pathogenesis of pemphigus vulgaris5
Hidradenitis suppurativa and rheumatoid arthritis: evaluating the bidirectional association5
Hyperprogressive disease in patients with advanced renal cell carcinoma: a new pattern of post-treatment cancer behavior5
Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors5
Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors5
Hypoxia modulates human mast cell adhesion to hyaluronic acid5
COVID-19 infection: a possible induction factor for development of autoimmune diseases?5
Involvement of age-associated B cells in EBV-triggered autoimmunity5
IL-21 enhances STAT3/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis5
Management of COVID-19 pneumonia in a child with NEMO deficiency5
Progressive decline of T and B cell numbers and function in a patient with CDC42 deficiency5
Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups5
0.077966928482056